Back to ZLTQ
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise

ZELTIQ® Aesthetics, Inc. (Nasdaq: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today named Mike Genau its President of the North American Franchise (NAF). In this role, Mr. Genau assumes leadership of the direct sales, sales operations and S.T.E.P. professionals (the field force providing sales training and enhanced practice marketing programs) for the company’s CoolSculpting business throughout the US and Canada.

Mr. Genau brings 24 years of healthcare industry experience to ZELTIQ. He has built an exceptional track record in sales, product management, marketing and general management with Fortune 100 and private equity-backed companies. His management responsibilities have included global, international, and domestic assignments for blue chip companies: Johnson & Johnson (JNJ), General Electric (GE), and Kinetic Concepts (KCI).

Mr. Genau will unify ZELTIQ’s commercial forces to deliver the highest possible level of practice support and enhancement in the aesthetic device category. The company’s commitment to partnering with each CoolSculpting practice will ultimately create an enduring brand and a growing consumer franchise that mutually benefits the practices and ZELTIQ.

“Mike is a strategist, a product management expert, a customer-focused sales executive and a dynamic leader,” said Gordie Nye, ZELTIQ chief executive officer. “Given his track record of accomplishments in leading organizations in competitive markets, I am thrilled to have him join our executive team. I anticipate that Mike will lead dramatic business growth; he will raise our group’s collective competitive zeal and collective experience, and I expect an immediate impact.”

Prior to joining ZELTIQ, Mr. Genau led Kinetic Concepts, Inc. (KCI) as president of the global Active Healing Solutions business, which represented 70 percent of the company’s revenue. While there, he played a key role in the successful sale of KCI to private equity group Apax Partners. Prior to that, he worked for GE Healthcare where he held executive and management positions for several key divisions within GE including: Global Diagnostic X-Ray and Mammography, Maternal Infant Care, Clinical Systems, GE Medical Systems Europe and Cardiology Systems.

Mr. Genau also served as Executive Vice President and General Manager for Critikon Company, LLC, where he played an instrumental role in the financial turnaround of the company that resulted in the successful sale of Critikon to GE Medical Systems. Earlier in his career, Mr. Genau held global sales, marketing, and product management positions for Johnson & Johnson.

About ZELTIQ

ZELTIQ® Aesthetics, Inc. (Nasdaq: ZLTQ) is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The Company’s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves or surrounding tissues. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat later within a treated fat bulge without requiring the patient to diet or exercise.

(c) 2014 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
Back to ZLTQ
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki